Key facts
- Taxo’s last known valuation is $30.0M (May 2024).
- It has raised $10.1M; the latest was Seed Round ($5.0M) in Mar 2025.
- Notable investors include Y Combinator, General Catalyst, 468 Capital, Hub71, Phoenix Investment Club (San Francisco) — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Taxo
- ·The full record, as it builds
Funding rounds
No funding rounds for Taxo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Taxo
Developer of a healthcare technology designed to automate administration processes. The company's platform utilizes artificial intelligence to automate the retrieval of clinical guidelines, verify insurance coverage, and streamline patient record management while adhering to the standards of data protection, enabling hospitals to focus more on patient care rather than administrative tasks.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 8
- Website
- taxo.ai/
- Ownership
- Privately Held (backing)
Taxo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Taxo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Taxo in its N-PORT filings yet. We sweep new filings monthly.